BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21763631)

  • 1. On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid.
    Klemke M; Drieschner N; Laabs A; Rippe V; Belge G; Bullerdiek J; Sendt W
    Cancer Genet; 2011 Jun; 204(6):334-9. PubMed ID: 21763631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
    Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
    Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J
    Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?
    Hibi Y; Nagaya T; Kambe F; Imai T; Funahashi H; Nakao A; Seo H
    Endocr J; 2004 Jun; 51(3):361-6. PubMed ID: 15256783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
    Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From the cytogenetics to the cytogenomics of thyroid tumors].
    Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
    Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
    Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
    Thyroid; 2006 Nov; 16(11):1091-6. PubMed ID: 17123335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.
    Dwight T; Thoppe SR; Foukakis T; Lui WO; Wallin G; Höög A; Frisk T; Larsson C; Zedenius J
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4440-5. PubMed ID: 12970322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
    Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
    Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
    Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
    Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
    Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
    Kroll TG; Sarraf P; Pecciarini L; Chen CJ; Mueller E; Spiegelman BM; Fletcher JA
    Science; 2000 Aug; 289(5483):1357-60. PubMed ID: 10958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
    Castro P; Roque L; Magalhães J; Sobrinho-Simões M
    Int J Surg Pathol; 2005 Jul; 13(3):235-8. PubMed ID: 16086077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.
    Lacroix L; Lazar V; Michiels S; Ripoche H; Dessen P; Talbot M; Caillou B; Levillain JP; Schlumberger M; Bidart JM
    Am J Pathol; 2005 Jul; 167(1):223-31. PubMed ID: 15972966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer.
    Zhang Y; Yu J; Grachtchouk V; Qin T; Lumeng CN; Sartor MA; Koenig RJ
    Oncotarget; 2017 Jan; 8(4):5761-5773. PubMed ID: 28008156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.